A start-up called Pectacea is making "solid progress" on a pioneering project that could create a completely new category of heart-healthy foods based on the ability of natural pectins to inhibit a ...

In a study led by Dr. Han Xiao (Department of cardiology and institute of vascular medicine, Peking university third hospital), researchers found that rapid over-activation of β-adrenergic receptors ...

A new study, published in Biochemistry this week, examines the biomechanics of sugar-seeking proteins. Specifically, it delves into galectin-3's interaction with glycosaminoglycans (GAG) and ...

A research group at the Department of Biochemistry and Molecular Biology of the University of Seville has made a significant advance by discovering the crucial role of the protein Galectin-3 in the ...

BOSTON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced ...

Scientists studying pectins that inhibit a protein called galectin-3 - elevated levels of which are associated with a higher risk of heart failure - say their work could create a completely new ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Researchers have measured the galectin-3 levels in the sera of hospitalized patients with coronavirus disease 2019 (COVID-19). They found initial high levels indicate patients will become severely ill ...

BOSTON, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a publicly listed company focused on the development of novel treatments for fibrosis and cancer, today announced that it has ...